Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)

Diabetic Medicine

Volumn 27, Issue 6, 2010, Pages 701-704

  Zampetti, S ^a   Spoletini, M ^a   Petrone, A ^a   Capizzi, M ^a   Arpi, M L ^b   Tiberti, C ^a   Di Pietro, S ^c   Bosi, E ^d,e   Pozzilli, P ^a   Giorgino, F ^f   Buzzetti, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Diabetes Unit   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY OF BARI   (Italy)

Author keywords

Autoimmunity; Diabetes; Genetics; Latent autoimmune diabetes of adults

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC LOAD; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LATENT AUTOIMMUNE DIABETES OF ADULT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPIC VARIATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AUTOANTIBODIES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; STATISTICS AS TOPIC; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 77952703354     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.02997.x     Document Type: Article

References (17)

1. Van Deutekom AW, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 2008 25 : 117 125.
2. Stenström G, Gottsäter A, Bakhtadze E, Berger B, Sundkvist G. Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 2005 54 : Suppl. 2 S68 S72.
3. Radtke MA, Midthjell K, Nilsen TI, Grill V. Heterogeneity of patients with LADA: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment. Results from the Nord-Trondelag Health study (HUNT). Diabetes Care 2009 32 : 245 250.
4. Buzzetti R, Di Pietro S, Giaccari A, Petrone A, Locatelli M, Suraci C et al. Non-Insulin Requiring Autoimmune Diabetes Study Group. High titre of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 2007 30 : 932 938.
5. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999 48 : 150 157.
6. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006 38 : 320 323.
7. Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008 57 : 1433 1437.
8. Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ et al. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia 2008 51 : 2224 2232.
9. Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C et al. The protein tyrosine phosphatase non-receptor 22 (PTPN22) is associated with high GAD antibody titre in latent autoimmune diabetes in adults: Non-Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3. Diabetes Care 2008 31 : 534 538.
10. Visalli N, Sebastiani L, Adorisio E, Conte A, De Cicco AL, D'Elia R et al. Environmental risk factors for type 1 diabetes in Rome and province. Arch Dis Child 2003 88 : 695 698.
11. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004 53 : 1782 1789.
12. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ et al. Islet autoantibody markers in insulin-dependent diabetes: risk assessment strategies yielding high sensitivity. Diabetologia 1995 38 : 816 822.
13. Bingley PJ, Bonifacio E, Mueller PW. Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 2003 52 : 1128 1136.
14. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 2006 55 : 2903 2908.
15. Desai M, Cull CA, Horton VA, Christie MR, Bonifacio E, Lampasona V et al. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia 2007 50 : 2052 2060.
16. Field SF, Howson JMM, Smyth DJ, Walker NM, Todd JA. Analysis of the Type 2 diabetes gene, TCF7L2, in 13 795 Type 1 diabetes cases and controls. Diabetologia 2007 50 : 212 213.
17. Yu J, Steck AK, Babu S, Yu L, Miao D, McFann K et al. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in anti-islet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab 2009 94 : 504 510.